Bayer and BlueRock Report Positive 36-Month Phase...
Category : Clinical Trial Update 9 October 2025Bayer AG and its wholly owned subsidiary BlueRock Therapeutics LP, a clinical-stage cell therapy com...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
Sequence LifeScience Enrolls First Patient in Clin...
Category : Clinical Trial Update 9 October 2025Sequence LifeScience Inc., a leader in allograft tissue processing, has announced a key milestone in...
Neurelis to Present New Pediatric Data on VALTOCO®...
Category : Product Related Updates 9 October 2025Neurelis, Inc., the neuroscience company behind VALTOCO® (diazepam nasal spray), announced it wi...
Positive Phase III Bax24 Results Show Baxdrostat S...
Category : Clinical Trial Update 8 October 2025AstraZeneca today announced positive topline results from the Phase III Bax24 trial, demonstrating t...
Skye Bioscience Reports Topline 26-Week Phase 2a C...
Category : Clinical Trial Update 8 October 2025Skye Bioscience, Inc., a clinical-stage biotech focused on novel therapies for obesity and metabolic...
Latest Newsletter Post
-
Neurelis to Present New Pediatric D..
9 October 2025
-
Sequence LifeScience Enrolls First..
9 October 2025
-
Bayer and BlueRock Report Positive..
9 October 2025
-
Eccogene Receives FDA Clearance to..
8 October 2025
-
Neurizon Therapeutics Announces FDA..
8 October 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com